Nvidia’s (NASDAQ:NVDA) core businesses have been firing on all cylinders, and its move into other profitable verticals has resulted in consistent top-line growth.  The company’s market value has grown at an incredible pace over the past decade. Yet, NVDA stock still has a ton of upside left with new catalysts that will amplify growth in
0 Comments
Any investment in Ocugen (NASDAQ:OCGN) stock is based on hope. That hope involves the FDA approving the Covid-19 vaccine known as Covaxin.    Source: shutterstock.com/PhotobyTawat Over the last six months or so, the company has repeatedly suggested that such an approval was imminent. On Feb. 2,  Ocugen announced an agreement with the Indian drug maker
0 Comments
Corporate ESG factors — that means environmental, social and governance considerations — are quickly becoming a metric to measure investment decisions. So, when asset managers with $10 trillion under their watch raise a red flag about a company’s exposure to physical climate risks, investors need to take notice. ESG stocks are not going away anytime
0 Comments
Mortgage rates saw notable upward movement across the board Tuesday, after taking a breather Monday following last week’s two-day climb. While the 30-year fixed rate average had been hovering just slightly above 3% for about a month, it now sits considerably higher, at its highest average since mid June. Today’s National Mortgage Rate Averages Mortgages
0 Comments
In this article LCID MU SHW Micron Technology headquarters in Biose, Idaho, March 28, 2021. Jeremy Erickson | Bloomberg | Getty Images Check out the companies making headlines after the bell Tuesday: Sherwin-Williams — The paint company saw its stock fall 3% in extended trading after the company lowered its third-quarter sales guidance. “The persistent
0 Comments
Just one month ago, sentiment surrounding mobile e-commerce company ContextLogic (NASDAQ:WISH) was positive. Seven analysts considered WISH stock a “buy” and four others rated the stock a “hold.” But these days, sentiment has darkened considerably. Currently, only three analysts have a “buy” rating on WISH stock, with six saying it’s a “hold” and two more
0 Comments
Biotech stocks are infamously one of the most volatile sectors in the stock market. Investors often venture into speculative companies with no proven pipelines. Emerging firms with a pipeline of drugs and products still in the clinical phase post little to no revenue. They raise cash by tapping capital markets to pay for research and
0 Comments
Hey everybody, Dave Bartosiak with Trending Stocks at Zacks.com. Remember, not too long ago, when Tesla was the only name in the EV space? You were either pro dinosaur fuel or pro environment, there was no in between. If you loved the environment, your tree hugging self had an effigy to Elon Musk, and you
0 Comments